Harmonization Eyed For EU Botanical Claim Regs, With Tighter Scrutiny
This article was originally published in The Tan Sheet
Two options are touted for botanical claims legislation in the EU – one would continue with the existing process under the European Food Safety Authority’s evaluation of claims for all types of supplement products and the other would align botanical regs with the medicines sector.
You may also be interested in...
European industry trade associations file a lawsuit to block the implementation of what they call EFSA’s restrictive list of permitted health claims. The groups demand the annulment of the general function claim list and ask the EC to “correct the flaws in its approach.”
The Traditional Herbal Medicinal Products Directive is poised to alter the landscape for herbal dietary supplements in the European Union
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.